Int J Pediatr EndocrinolInt J Pediatr EndocrinolInternational Journal of Pediatric Endocrinology1687-98481687-9856BioMed Central44286391687-9856-2015-S1-O1910.1186/1687-9856-2015-S1-O19Oral PresentationControversies of the assesment and management of polycystic ovary syndrome in adolescentsPeñaAlexia1DabadghaoPreeti2Department of Endocrinology/Diabetes, Women’s and Children’s Hospital, The University of Adelaide, Adelaide, SA, AustraliaDepartment of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India201528420152015Suppl 1Abstracts from the 8th APPES Biennial Scientific MeetingPublication of this supplement has not been supported by sponsorship.O19O19Copyright © 2015 Peña and Dabadghao; licensee BioMed Central Ltd.2015Peña and Dabadghao; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.29 October-1 November 20148th APPES Biennial Scientific MeetingDarwin, Australia<p>The diagnosis of polycystic ovary syndrome (PCOS) in adolescents is difficult as the pathological criteria used in adults like menstrual irregularities, acne, hirsutism and polycystic ovarian morphology could be normal physiological findings during puberty; in addition the syndrome is heterogeneous and there is limited high quality evidence. [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>] Three international conferences have been held reporting different criteria for diagnosis of PCOS in women [Table <xref ref-type="table" rid="T1">1</xref>]. [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>] The 2011 Australian PCOS evidence-based guideline [<xref ref-type="bibr" rid="B1">1</xref>], the 2012 international evidence-based workshop [<xref ref-type="bibr" rid="B2">2</xref>] and the 2013 Endocrine Society Clinical Practice Guideline [<xref ref-type="bibr" rid="B3">3</xref>] highlight the issues of applying adult criteria to diagnose PCOS in adolescents.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Diagnostic criteria for PCOS in women</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">PCOS definition</th><th align="left">Clinical (modified Ferriman-Gallway score >8*) or biochemical hyperandrogenemia (elevated total or free testosterone level **)</th><th align="left">Oligomenorrhoea (< 6-9 menstrual cycles per year) or oligo-anovulation</th><th align="left">Polycystic ovaries on ultrasound (>12 follicles in one ovary or volume >10 cc)</th></tr></thead><tbody><tr><td align="left">NICHD 1990 [<xref ref-type="bibr" rid="B4">4</xref>]</td><td align="left">Yes</td><td align="left">Yes</td><td align="left"/></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">Rotterdam 2003 [<xref ref-type="bibr" rid="B5">5</xref>]</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Yes</td></tr><tr><td align="left"/><td colspan="3"><hr/></td></tr><tr><td align="left"/><td align="left" colspan="3">2 of 3 criteria</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">AE-PCOS 2009 [<xref ref-type="bibr" rid="B6">6</xref>]</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Yes</td></tr><tr><td align="left"/><td align="left"/><td colspan="2"><hr/></td></tr><tr><td align="left"/><td align="left"/><td align="left" colspan="2">1 of 2 criteria</td></tr></tbody></table><table-wrap-foot><p>* Ethnicity should be considered when assessing hirsutism</p><p>**Testosterone assays, puberty and time of the sample should be considered when reviewing levels.</p></table-wrap-foot></table-wrap><p>All criteria require exclusion of other conditions: non-classic congenital adrenal hyperplasia, hypothyroidism, Cushing syndrome, hyperprolactinemia or androgen producing tumours which can cause a PCOS-like picture.</p><p>Although diagnosis of PCOS is based on its reproductive manifestations, it is a metabolic disorder. PCOS adolescents are at a high risk of having or developing glucose tolerance abnormalities, dyslipidemia and hypertension. Insulin resistance and the consequent development of hyperinsulinaemia seem to be the central pathophysiological mechanism that links PCOS to its associated metabolic derangements; this can occur independent of weight status. Obesity, which is commonly associated with PCOS, exaggerates insulin abnormalities. Adolescents with PCOS should have evaluation of glucose homeostasis and insulin resistance at diagnosis.</p><p>PCOS management should include a multidisciplinary team and should be individualized depending on the predominant complaint and weight status. Lifestyle modifications should be the first line treatment in the presence of overweight, obesity and/or insulin resistance. Metformin can also be added. Cyclical progesterone withdrawn bleed or cyclical oral contraceptive pills are used for menstrual irregularities. Antiandrogens like spironolactone and oral contraceptive pills are used for hirsutism. Permanent treatment with laser or electrolysis is usually advised after a course of antiandrogens.</p><p>Various aspects of adolescent PCOS will be discussed based on illustrative cases.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Teede</surname><given-names>HJ</given-names></name><name><surname>Misso</surname><given-names>ML</given-names></name><name><surname>Deeks</surname><given-names>AA</given-names></name><name><surname>Moran</surname><given-names>LJ</given-names></name><name><surname>Stuckey</surname><given-names>BJ</given-names></name><name><surname>Wong</surname><given-names>JL</given-names></name><etal/><article-title>Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline.</article-title><source>Med J Aust</source><year>2011</year><volume>195</volume><issue>6</issue><fpage>S65</fpage><lpage>S112</lpage><pub-id pub-id-type="doi">10.5694/mja11.10915</pub-id><pub-id pub-id-type="pmid">21929505</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book"><name><surname>Johnson</surname><given-names>T</given-names></name><etal/><source>NIH EbMW Report</source><year>2012</year><volume>1</volume><publisher-name>695 Bethesda, Maryland, National Institutes of Health</publisher-name><fpage>1</fpage><lpage>14</lpage><comment>(<ext-link ext-link-type="uri" xlink:href="http://prevention.nih.gov/workshops/2012/pcos/default.aspx">http://prevention.nih.gov/workshops/2012/pcos/default.aspx</ext-link>)</comment></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Arslanian</surname><given-names>SA</given-names></name><name><surname>Ehrmann</surname><given-names>DA</given-names></name><name><surname>Hoeger</surname><given-names>KM</given-names></name><name><surname>Murad</surname><given-names>MH</given-names></name><name><surname>Pasquali</surname><given-names>R</given-names></name><etal/><article-title>Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.</article-title><source>J Clin Endocrinol Metab</source><year>2013</year><volume>98</volume><issue>12</issue><fpage>4565</fpage><lpage>4592</lpage><pub-id pub-id-type="doi">10.1210/jc.2013-2350</pub-id><pub-id pub-id-type="pmid">24151290</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="book"><name><surname>Zawadzki</surname><given-names>JK</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name><person-group person-group-type="editor">Dunaif A, Givens JR, Haseltine FP, Merriam GR</person-group><article-title>Diagnostic criteria for polycystic ovary syndrome: towards a rational approach.</article-title><source>Polycystic Ovary Syndrome</source><year>1992</year><publisher-name>Boston: Blackwell Scientific Publications</publisher-name><fpage>377</fpage><lpage>384</lpage></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><collab>Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group</collab><article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.</article-title><source>Fertil Steril</source><year>2004</year><volume>81</volume><issue>1</issue><fpage>19</fpage><lpage>25</lpage></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Azziz</surname><given-names>R</given-names></name><name><surname>Carmina</surname><given-names>E</given-names></name><name><surname>Dewailly</surname><given-names>D</given-names></name><name><surname>Diamanti-Kandarakis</surname><given-names>R</given-names></name><name><surname>Escobar-Morreale</surname><given-names>HF</given-names></name><name><surname>Futterweit</surname><given-names>W</given-names></name><etal/><article-title>The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.</article-title><source>Fertil Steril</source><year>2009</year><volume>91</volume><issue>2</issue><fpage>456</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.06.035</pub-id><pub-id pub-id-type="pmid">18950759</pub-id></mixed-citation></ref></ref-list></back></article>